Acute Gallbladder Illness: Acute events of gallbladder condition including cholelithiasis or cholecystitis have already been documented in GLP-1 receptor agonist trials and postmarketing. In placebo-controlled trials, cholelithiasis was claimed in one. Wegovy® is made up of semaglutide and should not be coadministered with other semaglutide-containing goods or with any GLP-1 https://wilhelmf866wcl5.nico-wiki.com/user